VivoSeq
Psychiatry

Substance Use Disorder

0

Pipeline Programs

4

Active Trials

1

Companies Involved

Substance Use Disorder is an early-stage landscape with 0 programs across 1 company. The most active players are Alicia Bunger.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

9

clinical trials

Completed3 · 33%
Unknown status2 · 22%
Recruiting2 · 22%
Not yet recruiting1 · 11%
Enrolling by invitation1 · 11%

Trial Activity

9 trials

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)